Search Results - "Clark, Gregory O"

Leptin therapy in insulin-deficient type I diabetes by Wang, May-yun, Chen, Lijun, Clark, Gregory O, Lee, Young, Stevens, Robert D, Ilkayeva, Olga R, Wenner, Brett R, Bain, James R, Charron, Maureen J, Newgard, Christopher B, Unger, Roger H

“…In nonobese diabetic mice with uncontrolled type 1 diabetes, leptin therapy alone or combined with low-dose insulin reverses the catabolic state through…”
Get full text

Type 1 Diabetes Treatment beyond Insulin: Role of GLP-1 Analogs by Harrison, Lindsay B., Mora, Pablo F., Clark, Gregory O., Lingvay, Ildiko

“…Objective To observe the efficacy and safety of glucagonlike peptide-1 (GLP-1) analogs in type 1 diabetes in a real-life medical practice setting. Methods We…”
Get full text

Efficacy and Safety of Metreleptin Therapy in Patients With Type 1 Diabetes: A Pilot Study by Vasandani, Chandna, Clark, Gregory O, Adams-Huet, Beverley, Quittner, Claudia, Garg, Abhimanyu

“…To study the efficacy and safety of metreleptin therapy in patients with suboptimally controlled type 1 diabetes mellitus (T1DM). After a baseline period of 4…”
Get full text

Lipid homeostasis, lipotoxicity and the metabolic syndrome by Unger, Roger H., Clark, Gregory O., Scherer, Philipp E., Orci, Lelio

“…In the 20th century industrialized nations have become afflicted with an unprecedented pandemic of increased adiposity. In the United States, the epicenter of…”
Get full text

Iatrogenic hyperinsulinemia in type 1 diabetes: Its effect on atherogenic risk markers by Wang, May-Yun, Yu, Xinxin, Lee, Young, McCorkle, S. Kay, Clark, Gregory O, Strowig, Suzanne, Unger, Roger H, Raskin, Philip

“…Abstract Aims Insulin is lipogenic and may invoke inflammation. We wished to determine if well controlled human and mice with type 1 diabetes had iatrogenic…”
Get full text

Type 1 Diabetes Treatment Beyond Insulin by Harrison, Lindsay B., Mora, Pablo F., Clark, Gregory O., Lingvay, Ildiko

“…ObjectiveTo observe the efficacy and safety of glucagonlike peptide-1 (GLP-1) analogs in type 1 diabetes in a real-life medical practice setting.MethodsWe…”
Get full text

Glucose responsive insulin production from human embryonic germ (EG) cell derivatives by Clark, Gregory O., Yochem, Robert L., Axelman, Joyce, Sheets, Timothy P., Kaczorowski, David J., Shamblott, Michael J.

“…Type 1 diabetes mellitus subjects millions to a daily burden of disease management, life threatening hypoglycemia and long-term complications such as…”
Get full text

Cell therapies for type 1 diabetes mellitus by Shamblott, Michael J, Clark, Gregory O

“…Type 1 diabetes is caused by autoimmune destruction of pancreatic beta-cells and is characterised by absolute insulin insufficiency. The monocellular nature of…”
Get more information

Chapter 28 - Derivation and Differentiation of Human Embryonic Germ Cells by Shamblott, Michael J., Kerr, Candace L., Axelman, Joyce, Littlefield, John W., Clark, Gregory O., Patterson, Ethan S., Addis, Russell C., Kraszewski, Jennifer N., Kent, Kathleen C., Gearhart, John D.

Get full text

Chapter 42 - Derivation and Differentiation of Human Embryonic Germ Cells by Shamblott, Michael J., Kerr, Candace L., Axelman, Joyce, Littlefield, John W., Clark, Gregory O., Patterson, Ethan S., Addis, Russell C., Kraszewski, Jennifer N., Kent, Kathleen C., Gearhart, John D.

“…Embryonic germ (EG) cells are pluripotent stem cells derived from primordial germ cells (PGCs) that arise in the late embryonic and early fetal period of…”
Get full text